Corporate Interviews & Videos

Screenshot 2025-09-25 at 8.18.16 AM
September 22, 2025
Geert Kersten, CEO of CEL-SCI, discusses the innovative approach of using immunotherapy, specifically Multikine, in cancer treatment. He emphasizes the importance of the immune system in fighting cancer and the need for a paradigm shift in how cancer therapies are developed and administered.

Screenshot 2025-09-18 at 2.02.32 PM
September 9, 2025
An exclusive interview with Geert Kersten, CEO of CEL-SCI Corporation (NYSE American: CVM). Discover how CEL-SCI is advancing its lead immunotherapy, Multikine, through breakthrough regulatory pathways in both the U.S. and Saudi Arabia, while strengthening its financial and strategic position.
Screenshot 2025-03-26 at 11.53.40 AM

Screen Shot 2024-11-26 at 11.21.04 AM

Screen Shot 2024-10-25 at 10.05.33 AM

Screen Shot 2023-10-24 at 2.00.24 PM

Screen Shot 2022-10-19 at 9.31.10 AM

maxresdefault

[corporate]